Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CARBIDOPA
- Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects
- A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects
- Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes
- Pharmacological Agents for Chronic Spinal Cord Injury (SCI)
- Sustained Release Oral Formulation for Treatment of Parkinson's Disease
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
- The Role of Brain Dopamine in Chronic Pain
- Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
- Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions
- Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA
- Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease
- Novel Non-opioid Post-surgical Pain Treatment in Females
- NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
- A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
- Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
- Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease
- Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
- Research on Translational Outcomes of Alcohol (Project RETRO)
- PK Study of WD-1603 in Healthy Subjects
- Improving Quality of Life in Early Parkinson's Disease
- A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions
- Effects of 5HTP on the Injured Human Spinal Cord
- WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects
- 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
- Dopaminergic Dysfunction in Late-Life Depression
- FDOPA PET and Nutritional Support in Parkinson's Disease
- Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
- Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
- Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
- Neurobiological Drivers of Mobility Resilience: The Dopaminergic System
- Social Decision Making in Parkinson's Disease
- Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)
- AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia
- Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity
- Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
- Effects of 5HTP and LDOPA on CNS Excitability After SCI
- Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis
- Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)
- Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in PD Patients With Motor Fluctuations
- L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
- Enhancement of Stroke Rehabilitation With Levodopa
- A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations
- PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
- Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
- Microbiota Intervention to Change the Response of Parkinson's Disease
- A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
- Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
- Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease
- Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach
- Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
- Measuring Parkinson's Disease Progression
- Extension, Carbidopa-levodopa in Neovascular AMD
- Pharmacokinetic of Levodopa Study in Healthy Males
- Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
- Dose-finding Pharmacokinetic Study in Healthy Males
- Dose Ranging Study of Carbidopa-levodopa
- Carbidopa-levodopa in Neovascular AMD
- A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
- Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients
- A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets
- A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
- A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)
- Parkinsonian Brain Repair Using Human Stem Cells
- Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
- Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)
- Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients
- A Study of L-DOPA for Depression and Slowing in Older Adults
- A Clinical Study in Advanced Parkinson's Disease Investigating the Long Term Safety of ND0612 Administered as a Continuous SC Infusion
- Mucuna Pruriens Therapy in Parkinson's Disease
- A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults
- A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
- A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis
- Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
- A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
- A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
- A Clinical Study Investigating the Efficacy, Safety, Tolerability and Pharmacokinetics of ND0612H, a Solution of Levodopa/Carbidopa Administered as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease
- Pharmacokinetic Study in Healthy Volunteers
- Carbidopa for the Treatment of Excessive Blood Pressure Variability
- Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
- A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)
- Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
- A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
- Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease
- A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients
- Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation
- Infusion of Apomorphine: Long-term Safety Study
- Pharmacokinetic Study in Healthy Males
- A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
- Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
- The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa
- Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics
- Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
- A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients
- A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
- A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications
- Effect of L-dopa In Subacute Back Pain Population
- Targeting Dopamine Therapy in RLS
- A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations
- A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
- A Phase I/IIa Study of Safety, Tolerability and Plasma Concentration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in PD Patients
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers
- Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa
- Vision Response to Dopamine Replacement
- Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
- Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
- A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
- Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide
- Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa
- PharmacoMRI of Parkinson Disease
- Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic
- Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
- Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers
- A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
- Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury
- Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
- Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
- Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens
- A Trial of Levodopa in Angelman Syndrome
- A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients
- Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
- Dopaminergic Modulation of Cognition and Psychomotor Function
- Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
- Levodopa for the Treatment of Residual Amblyopia
- Trial of L-DOPA as a Treatment to Improve Vision in Albinism
- A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
- A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
- Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
- An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
- Levodopa Concentration Profile With Stalevo 75/125 mg
- Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
- A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy
- Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study
- Trial of Kuvan in Lesch-Nyhan Disease
- An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors
- Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
- A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
- Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
- Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
- Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
- Pharmacokinetic Study With Repeated Doses of Stalevo
- Peripheral Dopamine in Postural Tachycardia Syndrome
- Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD
- Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
- Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
- Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
- Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
- Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
- Treatment of Orthostatic Hypotension
- PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
- Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
- Augmenting Effects of L-DOPS With Carbidopa and Entacapone
- Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
- Low Dose Apomorphine and Parkinsonism
- Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
- A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
- 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
- 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
- Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
- Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
- Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
- Methylphenidate and Parkinson's Disease
- Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
- Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
- Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
- Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
- Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
- Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
- Treatment of Supine Hypertension in Autonomic Failure
- Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
- Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
- Medications for Stopping Cocaine Dependence and Preventing Relapse
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
- Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
- A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
- Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
- A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
- A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
- Stalevo in Early Wearing-Off Patients
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
- ACP-103 to Treat Parkinson's Disease
- 131MIBG to Treat Malignant Pheochromocytoma
Clinical trials list
click for details